Y mAbs Therapeutics (YMAB) Q3 2025 Earnings

8AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.26
-0.2
-0.13
-0.07

Details

Expected EPS
-0.263
Actual EPS
-0.07
Surprise EPS
0.19
Surprise Percent
+73.38%

Description

Y mAbs Therapeutics (YMAB) has reported earnings of -0.07 per share for Q3 2025.

0 Comments

Share your thoughts